Pharmaceutical Industry Payments and Oncologists’ Selection of Targeted Cancer Therapies in Medicare Beneficiaries-Reference-Cited by-同舟云学术

Pharmaceutical Industry Payments and Oncologists’ Selection of Targeted Cancer Therapies in Medicare Beneficiaries

Published:2018-06-01 Issue:6 Volume:178 Page:854
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Mitchell Aaron P.¹²³,Winn Aaron N.⁴⁵,Dusetzina Stacie B.⁶⁷

Affiliation:

1. Division of Hematology/Oncology, Department of Medicine, UNC School of Medicine, The University of North Carolina at Chapel Hill

2. Lineberger Comprehensive Cancer Center, UNC School of Medicine, The University of North Carolina at Chapel Hill

3. The Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill

4. School of Pharmacy, Medical College of Wisconsin, Milwaukee

5. Cancer Center, Medical College of Wisconsin, Milwaukee

6. Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee

7. Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Reference5 articles.

1. Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts.;Yeh;JAMA Intern Med,2016

2. Pharmaceutical industry–sponsored meals and physician prescribing patterns for Medicare beneficiaries.;DeJong;JAMA Intern Med,2016

3. Physician payments from industry are associated with greater Medicare Part D prescribing costs.;Perlis;PLoS One,2016

4. Forecasting unanticipated consequences of “The Sunshine Act”: mostly cloudy.;Ratain;J Clin Oncol,2014

5. Centers for Medicare & Medicaid Services. The facts about Open Payments data. https://openpaymentsdata.cms.gov/summary. Published 2016. Accessed March 4, 2018.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Industry Payments to Urology Residents: A Longitudinal Analysis Under the Sunshine Act;Journal of Surgical Education;2024-10

2. Cross‐sectional analysis of pharmaceutical industry payments to board‐certified breast cancer specialists in Japan;Clinical and Translational Discovery;2024-08

3. Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set;JCO Oncology Practice;2024-06

4. Pharmaceutical company payments to Japanese breast cancer practice guideline authors;Clinical and Translational Discovery;2024-06

5. Evaluation of non-research and research industry payments to pediatric hematologist/oncologists in the United States between 2013 and 2021;Leukemia & Lymphoma;2024-02-13